• Citer

A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.

par Body, Jean-Jacques ;Gaich, Gregory A;Scheele, Wim H;Kulkarni, Pandurang M;Miller, Paul;Peretz, Anne ;Dore, Robin K;Correa-Rotter, Ricardo;Papaioannou, Alexandra;Cumming, David C;Hodsman, Anthony B
Référence The Journal of clinical endocrinology and metabolism, 87, 10, page (4528-4535)
Publication Publié, 2002-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.
Auteur:	Body, Jean-Jacques; Gaich, Gregory A; Scheele, Wim H; Kulkarni, Pandurang M; Miller, Paul; Peretz, Anne; Dore, Robin K; Correa-Rotter, Ricardo; Papaioannou, Alexandra; Cumming, David C; Hodsman, Anthony B
Informations sur la publication:	The Journal of clinical endocrinology and metabolism, 87, 10, page (4528-4535)
Statut de publication:	Publié, 2002-10
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Alendronate -- therapeutic use
	Alkaline Phosphatase -- blood
	Biological Markers
	Body Height -- drug effects
	Bone Density -- drug effects
	Bone Remodeling -- drug effects
	Bone Resorption -- prevention & control
	Bone and Bones -- enzymology -- injuries
	Calcitriol -- blood
	Collagen -- urine
	Collagen Type I
	Double-Blind Method
	Female
	Fractures, Bone -- prevention & control
	Humans
	Middle Aged
	Osteoporosis, Postmenopausal -- drug therapy
	Peptides -- urine
	Teriparatide -- therapeutic use
Note générale:	Clinical Trial
	Comparative Study
	Journal Article
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0021-972X
	info:doi/10.1210/jc.2002-020334
	info:scp/18644374464
	info:pmid/12364430